273 related articles for article (PubMed ID: 25797029)
101. Cardiotonic steroids stabilize regulator of G protein signaling 2 protein levels.
Sjögren B; Parra S; Heath LJ; Atkins KB; Xie ZJ; Neubig RR
Mol Pharmacol; 2012 Sep; 82(3):500-9. PubMed ID: 22695717
[TBL] [Abstract][Full Text] [Related]
102. Formation of new high density glycogen-microtubule structures is induced by cardiac steroids.
Fridman E; Lichtstein D; Rosen H
J Biol Chem; 2012 Feb; 287(9):6518-29. PubMed ID: 22228762
[TBL] [Abstract][Full Text] [Related]
103. Cardiac glycosides inhibit cancer through Na/K-ATPase-dependent cell death induction.
Geng X; Wang F; Tian D; Huang L; Streator E; Zhu J; Kurihara H; He R; Yao X; Zhang Y; Tang J
Biochem Pharmacol; 2020 Dec; 182():114226. PubMed ID: 32976831
[TBL] [Abstract][Full Text] [Related]
104. 21-Benzylidene digoxin decreases proliferation by inhibiting the EGFR/ERK signaling pathway and induces apoptosis in HeLa cells.
Pessôa MTC; Valadares JMM; Rocha SC; Silva SC; McDermott JP; Sánchez G; Varotti FP; Scavone C; Ribeiro RIMA; Villar JAFP; Blanco G; Barbosa LA
Steroids; 2020 Mar; 155():108551. PubMed ID: 31812624
[TBL] [Abstract][Full Text] [Related]
105. Na+/K+-ATPase alpha subunits as new targets in anticancer therapy.
Mijatovic T; Ingrassia L; Facchini V; Kiss R
Expert Opin Ther Targets; 2008 Nov; 12(11):1403-17. PubMed ID: 18851696
[TBL] [Abstract][Full Text] [Related]
106. Studies on cardiac ingredients of plants. XIII: Chemical modification of gitoxin to cardiotonic compounds without vascular effect.
Nagatsu A; Nakamura Y; Takemoto K; Shibatomi K; Nagai S; Ueda T; Sakakibara J; Hidaka H; Fujita M; Hotta Y; Takeya K; Asano M; Hashimoto T; Asakawa Y
Chem Pharm Bull (Tokyo); 1997 Apr; 45(4):599-607. PubMed ID: 9145499
[TBL] [Abstract][Full Text] [Related]
107. Toad toxin-resistant snake (Thamnophis elegans) expresses high levels of mutant Na
Mohammadi S; Savitzky AH; Lohr J; Dobler S
Gene; 2017 May; 614():21-25. PubMed ID: 28249773
[TBL] [Abstract][Full Text] [Related]
108. Epistatic Effects Between Amino Acid Insertions and Substitutions Mediate Toxin resistance of Vertebrate Na+,K+-ATPases.
Mohammadi S; Özdemir Hİ; Ozbek P; Sumbul F; Stiller J; Deng Y; Crawford AJ; Rowland HM; Storz JF; Andolfatto P; Dobler S
Mol Biol Evol; 2022 Dec; 39(12):. PubMed ID: 36472530
[TBL] [Abstract][Full Text] [Related]
109. The physiological and clinical importance of sodium potassium ATPase in cardiovascular diseases.
Yan Y; Shapiro JI
Curr Opin Pharmacol; 2016 Apr; 27():43-9. PubMed ID: 26891193
[TBL] [Abstract][Full Text] [Related]
110. Synthesis and Cytotoxicity of Diarylpentanoids against Sensitive CCRF-CEM and Multidrug-Resistant CEM/ADR5000 Leukemia Cells.
Di Chio C; Zhou M; Efferth T; Schirmeister T; Zappalà M; Ettari R
Chem Biodivers; 2022 Feb; 19(2):e202100451. PubMed ID: 34871465
[TBL] [Abstract][Full Text] [Related]
111. Cardiac Glycosides as Immune System Modulators.
Škubník J; Pavlíčková V; Rimpelová S
Biomolecules; 2021 Apr; 11(5):. PubMed ID: 33947098
[TBL] [Abstract][Full Text] [Related]
112. Acute sodium loading in Dahl-s rats: alterations in renal and vascular sodium pump inhibition amidst unaltered cardiotonic steroid levels?
Van Huysse JW
Am J Hypertens; 2009 May; 22(5):471-2. PubMed ID: 19387431
[No Abstract] [Full Text] [Related]
113. Contrasting effects of cardiac glycosides on cisplatin- and etoposide-induced cell death.
Kulikov AV; Slobodkina EA; Alekseev AV; Gogvadze V; Zhivotovsky B
Biol Chem; 2016 Jul; 397(7):661-70. PubMed ID: 26854291
[TBL] [Abstract][Full Text] [Related]
114. A previously undescribed phenylethanoid glycoside from Callicarpa kwangtungensis Chun acts as an agonist of the Na/K-ATPase signal transduction pathway.
Xu Y; Jiang X; Xu J; Qu W; Xie Z; Jiang RW; Feng F
Phytochemistry; 2021 Jan; 181():112577. PubMed ID: 33190100
[TBL] [Abstract][Full Text] [Related]
115. New Knowledge About Old Drugs: The Anti-Inflammatory Properties of Cardiac Glycosides.
Fürst R; Zündorf I; Dingermann T
Planta Med; 2017 Aug; 83(12-13):977-984. PubMed ID: 28297727
[TBL] [Abstract][Full Text] [Related]
116. Enhancing the anticancer properties of cardiac glycosides by neoglycorandomization.
Langenhan JM; Peters NR; Guzei IA; Hoffmann FM; Thorson JS
Proc Natl Acad Sci U S A; 2005 Aug; 102(35):12305-10. PubMed ID: 16105948
[TBL] [Abstract][Full Text] [Related]
117. Cell volume and monovalent ion transporters: their role in cell death machinery triggering and progression.
Orlov SN; Platonova AA; Hamet P; Grygorczyk R
Am J Physiol Cell Physiol; 2013 Aug; 305(4):C361-72. PubMed ID: 23615964
[TBL] [Abstract][Full Text] [Related]
118. Mutations to the cardiotonic steroid binding site of Na(+)/K(+)-ATPase are associated with high level of resistance to gamabufotalin in a natricine snake.
Mohammadi S; Brodie ED; Neuman-Lee LA; Savitzky AH
Toxicon; 2016 May; 114():13-5. PubMed ID: 26905927
[TBL] [Abstract][Full Text] [Related]
119. Endogenous cardiotonic steroids and cardiovascular disease, where to next?
Pavlovic D
Cell Calcium; 2020 Mar; 86():102156. PubMed ID: 31896530
[TBL] [Abstract][Full Text] [Related]
120. (+)-Strebloside-Induced Cytotoxicity in Ovarian Cancer Cells Is Mediated through Cardiac Glycoside Signaling Networks.
Chen WL; Ren Y; Ren J; Erxleben C; Johnson ME; Gentile S; Kinghorn AD; Swanson SM; Burdette JE
J Nat Prod; 2017 Mar; 80(3):659-669. PubMed ID: 28234008
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
